A recent article in Seeking Alpha focused on the traditional role of some of Wall Street’s biggest players: hedge funds.In the six-year bull market that has taken the S&P 500 to new all-time highs, there has been little need for hedging or protection from a weak stock market. However, a large part of what hedge funds are meant to do […]
You must subscribe to access archives olderthan one year.Take a free trial of Briefing In Play® now.TERMS OF USEThe Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by […]
More Charts
Market complacency has re-emerged, warns Deutsche Bank’s David Bianco.His preferred measure of this is the PE / VIX ratio. (PE is short for price-earnings, a measure of stock market value. The VIX is the CBOE volatility index, a rough measure of “fear” in the stock market.)From Bianco’s note: “Our PE/VIX market emotion indicator climbed to 1.3 on S&P trailing […]
You must subscribe to access archives olderthan one year.Take a free trial of Briefing In Play® now.TERMS OF USEThe Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by […]
You must subscribe to access archives olderthan one year.Take a free trial of Briefing In Play® now.TERMS OF USEThe Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by […]
You must subscribe to access archives olderthan one year.Take a free trial of Briefing In Play® now.TERMS OF USEThe Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by […]
You must subscribe to access archives olderthan one year.Take a free trial of Briefing In Play® now.TERMS OF USEThe Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by […]
Sarepta Therapeutics (NASDAQ:SRPT)After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy — DMD — to restore dystrophin […]
You must subscribe to access archives olderthan one year.Take a free trial of Briefing In Play® now.TERMS OF USEThe Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by […]
You must subscribe to access archives olderthan one year.Take a free trial of Briefing In Play® now.TERMS OF USEThe Briefing.com RSS (really simple syndication) service is a method by which we offer story headline feeds in XML format to readers of the Briefing.com web site who use RSS aggregators. By using Briefing.com’s RSS service you agree to be bound by […]
